REQUEST A DEMO
Total
USD $0.00
Search more companies

Aakash Pharma Private Limited (India)

Main Activities: Wholesale Electronic Markets and Agents and Brokers
Full name: Aakash Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Aakash Pharma Private Limited is based in India. The head office is in Madurai. It operates in the Wholesale Electronic Markets and Agents and Brokers sector. Aakash Pharma Private Limited was incorporated on June 19, 2015. It currently has a total number of 17 (2025) employees. From the latest financial highlights, Aakash Pharma Private Limited reported a net sales revenue drop of 4.38% in 2025. Its’ total assets recorded a growth of 96.87%. In, 2025, the company’s net profit margin increased by 0.38%.

Legal Address
5/9, Anjal Nagar 3Rd Cross Street Vilangudi
Madurai; Tamil Nadu; Postal Code: 625018

Contact Details: Purchase the Aakash Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Aakash Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Aakash Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Aakash Pharma Private Limited report to view the information.
Incorporation Date:
June 19, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Aakash Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-4.38%
Total Operating Revenue
-4.38%
Operating Profit
13.29%
EBITDA
12.09%
Net Profit/Loss for the Period
13.06%
Total Assets
96.87%
Total Equity
20.98%
Operating Profit Margin
0.54%
Net Profit Margin
0.38%
Return on Equity (ROE)
-1.21%
Quick Ratio
0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?